Both in Pharmaceuticals
ABVC BioPharma vs China Pharma Holdings
Over the past year ABVC returned −66.6% and CPHI returned −61.1%; their daily moves had a correlation of 0.09.
ABVC −66.6% CPHI −61.1%Growth of $1, one year, split-adjusted
| Metric | ABVC | CPHI |
|---|---|---|
| Price | $0.9900 | $0.6348 |
| Market cap | $26.4M | $27.3M |
| Today | +1.01% | +4.70% |
| 1 month | +1.0% | −2.8% |
| 6 months | −3.9% | +15.0% |
| Year to date | −53.5% | −47.5% |
| 1 year | −64.6% | — |
| Revenue growth (YoY) | — | −7.5% |
| Gross margin | — | 8.8% |
| Net margin | — | −153.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 7.0× |
| Net cash | $34.9K | -$3.3M |
| Dividend yield | — | — |
| Volatility (60d) | 78.0% | 90.8% |
| Short % of float | 2.7% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).